AFTER SEVEN days of deliberation and a flurry of notes to the judge about deadlock, a 12-member jury in Silicon Valley found Elizabeth Holmes, the entrepreneur behind a once promising phlebotomy startup, guilty of four counts of fraudulently deceiving investors. Each count carries a prison term of up to 20 years. She was acquitted of four charges of deceiving patients and doctors; on three others the jury were deadlocked leading to a potential re-trial. The verdict, against which Ms Holmes’s lawyers are expected to appeal, marks the fall of a career that beguiled the media, politicians and many in business.
After dropping out of Stanford in 2003 at the age
→ Continue reading at The Economist
